Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A Phase I/II Study of GVV858 Alone or in Drug Combination for Patients with Advanced Hormone Receptor‑Positive, HER2‑Negative Breast Cancer

    Recruiting

    2 1 1 1
    Czechia Denmark France Germany Italy Spain
  • Zongertinib for Cancer in Patients Eligible for Early Access Treatment

    Recruiting

    2 1 1
    Investigated Drugs:
    Finland
  • A study of PM54 and pembrolizumab in adults with advanced cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • A study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene

    Recruiting

    1 1 1 1
    France Germany Italy Poland Spain
  • A study to test the safety and effectiveness of BAY 3713372 alone and with drug combination in patients with MTAP-deleted solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Belgium Czechia Denmark Italy The Netherlands Spain +1
  • Study of ipilimumab and nivolumab injected into tumors before surgery in patients with stage III melanoma that can be removed by surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • A study of S-241656 and a drug combination in patients with certain types of cancer involving KRAS, BRAF, or other RAS/MAPK mutations

    Recruiting

    2 1 1 1
    Denmark France Italy Spain
  • Phase 1/2A Study of OTP-01 to Evaluate Safety and Anti‑Tumor Activity in Patients with Advanced Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    Ireland Portugal Spain
  • A study of YL201 and atezolizumab for patients with advanced solid tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy Poland +2
  • A Study of IPN60300 in Adults with Locally Advanced or Metastatic Solid Tumors to Assess Safety, Tolerability and Anti-Cancer Activity

    Recruiting

    2 1 1
    Investigated Diseases:
    France Spain